Skip to main content

Delivery of salbutamol and of budesonide from a novel multi-dose inhaler Airmax(TM)

Zeng, Xian-Ming, O'Leary, C., Phelan, M., Jones, S., Colledge, J. (2002) Delivery of salbutamol and of budesonide from a novel multi-dose inhaler Airmax(TM). Respiratory Medicine, 96 (6). pp. 404-411. ISSN 0954-6111. (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:1006)

The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided. (Contact us about this Publication)

Abstract

This paper discussed the design features and performance characteristics of a novel multidose dry powder inhaler, the AirmaxTM inhaler which has been launched in several European countries. The inhaler was designed to closely approach the characteristics of an “ideal” inhaler. After its launch in various EU countries, the inhaler is becoming increasingly popular among the clinicians and the patients.

Item Type: Article
Subjects: Q Science > Q Science (General)
R Medicine > RS Pharmacy and materia medica
Divisions: Divisions > Division of Natural Sciences > Medway School of Pharmacy
Depositing User: Sara Witchell
Date Deposited: 19 Dec 2007 18:40 UTC
Last Modified: 16 Feb 2021 12:13 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/1006 (The current URI for this page, for reference purposes)
  • Depositors only (login required):